BriaCell Therapeutics Minority Interest

BriaCell Therapeutics (BCTX) currently reports a minority interest of $-650K as of April 2026. That compares with $-470K in the prior-year period — down 36.9% year over year. Use the charts on this page to explore BriaCell Therapeutics's minority interest history and peer comparisons.

BriaCell Therapeutics's minority interest decreased from $-470K to $-650K — a 36.9% year-over-year decrease (period ending April 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

BriaCell Therapeutics reported $-650K in minority interest as of April 2026. That compares with $-470K in the prior-year period — down 36.9% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current minority interest of $-650K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for BriaCell Therapeutics, and consider following BCTX for alerts when major investors trade the stock.

BriaCell Therapeutics is classified in the Healthcare sector. On minority interest, it currently shows $-650K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BCTX with unrelated industries.